WeightWatchers has conducted a 6-month clinical trial of 180 participants on GLP-1 medication (Heinberg et al.), but the manuscript is under review and has not yet been published in a peer-reviewed journal
Patient and outcome images on the site appear authentic, with no obvious AI-generated or stock-style imagery on the marketing pages
Relative to the other precursors, NMN has only recently been tested in clinical trials for treating age-related deficits
[453] Comment: A few commenters requested clarification on, or seemed to misinterpret, our proposal to replace the estimated allowed amount with the median allowed amount
Glutathione use is frequently promoted mostly by pharmaceutical cosmetic companies, targeting ethnic communities who have darker skin tones
3.6 Stroke and post-stroke cognitive impairment (PSCI) Post-stroke patients show gut dysbiosis with reduced microbial diversity, increased pro-inflammatory bacteria, and decreased levels of SCFA-producing bacteria such as Faecalibacterium (Yin et al., 2015)
